Log in to save to my catalogue

L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8985842

L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

About this item

Full title

L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Pediatric nephrology (Berlin, West), 2021-08, Vol.36 (8), p.2411-2419

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Hypertension is common among children with chronic kidney disease (CKD), and dihydropyridine calcium channel blockers (dhCCBs) are frequently used as treatment. The impact of dhCCBs on proteinuria in children with CKD is unclear.
Methods
Data from 722 participants in the Chronic Kidney Disease in Children (CKiD) longitudinal coh...

Alternative Titles

Full title

L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8985842

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8985842

Other Identifiers

ISSN

0931-041X

E-ISSN

1432-198X

DOI

10.1007/s00467-021-04967-3

How to access this item